メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
東北大学 ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
プレス/メディア
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
唐澤 秀明
助教
大学病院・外科
h-index
950
被引用数
19
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2008
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(72)
類似のプロファイル
(6)
フィンガープリント
Hideaki Karasawaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Rectum Cancer
100%
Neoplasm
86%
Lymph Node Metastasis
47%
Recurrent Disease
43%
Colorectal Carcinoma
43%
Cancer Cell
37%
Chemoradiotherapy
36%
Lower Anterior Resection
34%
Bladder
30%
Lymph Node
30%
Pancreas Cancer
26%
Adenocarcinoma
26%
Abdominal Cancer
23%
Abdominoperineal Resection
20%
Gemcitabine
20%
Sigmoid
20%
Laparotomy
20%
Distant Metastasis
19%
Organoid
19%
Colonoscopy
17%
Cancer Growth
17%
Ileo-Anal Pouch
17%
Adjuvant Chemotherapy
16%
Small Intestine
16%
Proctocolectomy
16%
Liver Metastasis
15%
Rectum Tumor
15%
Neoadjuvant Chemotherapy
15%
Pelvis
15%
Colon
15%
Bladder Metastasis
15%
Metastatic Carcinoma
14%
Malignant Neoplasm
14%
Gastrointestinal Stromal Tumor
14%
Promoter Region
14%
Imatinib
14%
Computer Assisted Tomography
14%
Primary Tumor
14%
Conversion Therapy
13%
Cholangiocarcinoma
13%
Adenoma
13%
Sigmoid Cancer
13%
Crohn's Disease
13%
Preoperative Chemotherapy
13%
Ulcerative Colitis
13%
Gallbladder Cancer
13%
Cancer Associated Fibroblast
13%
Laparoscopic Surgery
13%
In Vitro
13%
Anal Canal
12%
Biochemistry, Genetics and Molecular Biology
Cripto
53%
Cancer Cell
44%
Promoter Region
15%
down Regulation
14%
Cancer Stem Cell
14%
N-Myc
13%
Fibroblast
13%
Carcinogenesis
12%
Cell Proliferation
11%
Cell Migration
10%
Colon
9%
Embryonic Stem Cell
9%
Methylation
8%
Small Interfering RNA
8%
Mesenchymal-Epithelial Transition
8%
Catenin
8%
Exon
8%
Fluorouracil
8%
MAPK Signaling
7%
Co-Receptor
7%
RNAI
7%
Programmed Cell Death
7%
Embryogenesis
7%
Multidrug Resistance
6%
Inhibitor of Apoptosis
6%
LRP5
6%
LRP6
6%
Extracellular Signal-Regulated Kinases
6%
KRAS
6%
DKK1
6%
Gene Ontology
6%
Cell Adhesion
6%
Splicing Factor
6%
Nuclear DNA
6%
Liquid Chromatography-Mass Spectrometry
6%
Nuclear Receptor
6%
Adenosine Triphosphate
6%
Precursor mRNA
6%
ABCC3
6%
Notch Signaling Pathway
6%
Deoxycholic Acid
6%
Proteomics
6%
Transcriptome
6%
Calreticulin
6%
P53
6%
Anticancer
6%
Tumor Progression
5%
Tandem Mass Spectrometry
5%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Carcinoma
57%
Malignant Neoplasm
23%
Colon Carcinoma
16%
Pancreas Cancer
13%
Mouse Model
11%
Carcinogenesis
11%
Colorectal Adenoma
9%
Neoplasm
9%
Cancer Growth
8%
Protein P53
7%
Recurrent Disease
7%
Messenger RNA
7%
Lymph Node Metastasis
7%
Estrogen Receptor
6%
Tumor Necrosis Factor
6%
Bile Duct Carcinoma
6%
Sequestosome 1
6%
Digestive System Cancer
6%
Hexokinase
6%
Inflammation
6%
Indole
6%
Multidrug Resistance
6%
Complementary DNA
6%
Transcription Factor RUNX2
6%
Fibrinogen
6%
microRNA
6%
ABC Transporter Subfamily G
6%
Cancer Growth Factor
6%
Rectum Cancer
6%
Cancer Model
6%
Abdominal Cancer
6%
Calreticulin
6%
Anticancer Drug
6%
Patient-Derived Organoid
6%
Phosphotransferase Inhibitor
6%
Mitogen Activated Protein Kinase
6%
Inhibitor of Apoptosis Protein
5%
Diseases
5%
